{"product_id":"test-urinaire-a-tremper-13-drogues","title":"Test Urinario 13 Droghe Drugdiag® 13T - Nuove Droghe di sintesi","description":"\u003cstyle\u003e\n\/* =========================================================\n   AMA Prévention — B-SAFE\n   Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n   Sans JS — prêt Shopify\n   ========================================================= *\/\n\n.ama-bsafe-2026 {\n  --ama-blue: #004C96;\n  --ama-blue-deep: #003B78;\n  --ama-blue-night: #00325f;\n  --ama-orange: #FE4B09;\n  --ama-text: #004C96;\n  --ama-muted: #667085;\n  --ama-border: #dbe6f2;\n  --ama-soft: #f6f9fd;\n  --ama-white: #ffffff;\n\n  width: 100%;\n  max-width: 1180px;\n  margin: 0 auto;\n  padding: 0;\n  font-family: inherit;\n  color: var(--ama-text);\n  background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n  box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n  min-width: 0;\n}\n\n.ama-bsafe-panel {\n  width: 100%;\n  position: relative;\n  overflow: hidden;\n  isolation: isolate;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 28px;\n  background:\n    radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n    radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n    linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n  box-shadow:\n    0 22px 55px rgba(0, 76, 150, 0.10),\n    inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n  width: 100%;\n  padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n  margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n  display: inline-flex;\n  align-items: center;\n  gap: 8px;\n  margin-bottom: 14px;\n  padding: 7px 12px;\n  border-radius: 999px;\n  background: rgba(0, 76, 150, 0.08);\n  color: var(--ama-blue);\n  font-size: 12px;\n  font-weight: 900;\n  letter-spacing: 0.04em;\n  text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n  content: \"\";\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n  margin: 0 0 16px;\n  color: var(--ama-blue);\n  font-size: clamp(30px, 4vw, 46px);\n  line-height: 1.08;\n  font-weight: 900;\n  letter-spacing: -0.045em;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n  margin: 0 0 16px;\n  color: var(--ama-text);\n  font-size: clamp(16px, 1.4vw, 18px);\n  line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n  color: var(--ama-blue);\n  font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n  display: flex;\n  flex-wrap: wrap;\n  gap: 10px;\n  margin-top: 26px;\n  padding: 14px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 20px;\n  background: rgba(255, 255, 255, 0.72);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n  display: inline-flex;\n  align-items: center;\n  gap: 8px;\n  flex: 1 1 230px;\n  padding: 10px 12px;\n  border-radius: 999px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  border: 1px solid rgba(0, 76, 150, 0.10);\n  color: var(--ama-blue);\n  font-size: 14px;\n  font-weight: 850;\n  line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n  content: \"\";\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n  flex-shrink: 0;\n}\n\n\/* =========================================================\n   Accordéon principal\n   Fermé : bleu nuit\n   Ouvert : clair + contenu dans le même bloc\n   ========================================================= *\/\n\n.ama-bsafe-accordion {\n  width: 100%;\n  max-width: 920px;\n  margin: 0 auto;\n  display: grid;\n  gap: 12px;\n}\n\n.ama-bsafe-item {\n  border-radius: 24px;\n  overflow: hidden;\n  background:\n    linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n  border: 1px solid rgba(0, 76, 150, 0.26);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.22),\n    inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n    0 16px 36px rgba(0, 76, 150, 0.17);\n  transition:\n    background 220ms ease,\n    box-shadow 220ms ease,\n    border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n  background:\n    radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n    linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n  border-color: rgba(0, 76, 150, 0.14);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.98),\n    0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n  position: relative;\n  min-height: 66px;\n  padding: 14px 58px 14px 18px;\n  display: flex;\n  align-items: center;\n  cursor: pointer;\n  list-style: none;\n  user-select: none;\n  -webkit-tap-highlight-color: transparent;\n  color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n  display: none;\n}\n\n.ama-bsafe-item[open] summary {\n  color: var(--ama-blue);\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n  border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n  content: \"+\";\n  position: absolute;\n  right: 16px;\n  top: 50%;\n  width: 36px;\n  height: 36px;\n  transform: translateY(-50%);\n  border-radius: 999px;\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  color: #ffffff;\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n  border: 1px solid rgba(255, 255, 255, 0.26);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.30),\n    0 10px 22px rgba(0, 0, 0, 0.14);\n  font-size: 22px;\n  font-weight: 760;\n  line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n  content: \"−\";\n  color: var(--ama-blue);\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n  border-color: rgba(0, 76, 150, 0.10);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.96),\n    0 8px 18px rgba(0, 76, 150, 0.10);\n  font-size: 24px;\n  font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n  .ama-bsafe-item:not([open]):hover {\n    box-shadow:\n      inset 0 1px 0 rgba(255, 255, 255, 0.26),\n      inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n      0 20px 44px rgba(0, 76, 150, 0.22);\n  }\n\n  .ama-bsafe-item[open]:hover {\n    box-shadow:\n      inset 0 1px 0 rgba(255, 255, 255, 0.98),\n      0 18px 42px rgba(0, 76, 150, 0.13);\n  }\n}\n\n.ama-bsafe-acc-title {\n  display: block;\n  font-size: 16px;\n  line-height: 1.18;\n  font-weight: 800;\n  letter-spacing: -0.018em;\n  color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n  display: block;\n  margin-top: 3px;\n  font-size: 13px;\n  line-height: 1.24;\n  font-weight: 650;\n  letter-spacing: -0.01em;\n  color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n  color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n  padding: clamp(20px, 4vw, 34px);\n  background: transparent;\n  animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n  from {\n    opacity: 0;\n    transform: translateY(5px);\n  }\n\n  to {\n    opacity: 1;\n    transform: translateY(0);\n  }\n}\n\n\/* =========================================================\n   Contenu\n   ========================================================= *\/\n\n.ama-bsafe-content h2 {\n  margin: 0 0 18px;\n  color: var(--ama-blue);\n  font-size: clamp(24px, 3vw, 36px);\n  line-height: 1.10;\n  font-weight: 900;\n  letter-spacing: -0.04em;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n  content: \"\";\n  display: block;\n  width: 78px;\n  height: 4px;\n  margin-top: 14px;\n  border-radius: 999px;\n  background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n  margin: 0 0 10px;\n  color: var(--ama-blue);\n  font-size: clamp(18px, 1.7vw, 23px);\n  line-height: 1.18;\n  font-weight: 900;\n  letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n  margin: 0 0 18px;\n  color: var(--ama-text);\n  font-size: 16px;\n  line-height: 1.72;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n  display: grid;\n  grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n  gap: 18px;\n  margin: 26px 0;\n}\n\n.ama-bsafe-card {\n  position: relative;\n  min-height: 150px;\n  padding: 24px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 22px;\n  background: rgba(255, 255, 255, 0.86);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  overflow-wrap: break-word;\n  transition:\n    transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n  margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n  .ama-bsafe-card:hover,\n  .ama-bsafe-substance-row:hover {\n    transform: translateY(-2px);\n    border-color: rgba(254, 75, 9, 0.32);\n    background: #ffffff;\n    box-shadow:\n      0 16px 34px rgba(0, 76, 150, 0.10),\n      inset 0 1px 0 rgba(255, 255, 255, 0.95);\n  }\n}\n\n.ama-bsafe-substance-list {\n  display: grid;\n  gap: 12px;\n  margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n  width: 100%;\n  display: flex;\n  align-items: center;\n  flex-wrap: wrap;\n  gap: 12px 18px;\n  padding: 16px 18px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 20px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  transition:\n    transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  flex: 0 0 130px;\n  width: 130px;\n  min-width: 130px;\n  max-width: 130px;\n  min-height: 38px;\n  padding: 7px 14px;\n  border-radius: 999px;\n  background: rgba(0, 76, 150, 0.08);\n  color: var(--ama-blue);\n  font-size: 15px;\n  font-weight: 950;\n  letter-spacing: -0.01em;\n  text-align: center;\n}\n\n.ama-bsafe-substance-main {\n  flex: 1 1 420px;\n  min-width: min(100%, 320px);\n  color: var(--ama-text);\n  font-size: 15px;\n  line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  flex: 0 0 auto;\n  margin-left: auto;\n  min-height: 34px;\n  padding: 6px 12px;\n  border-radius: 999px;\n  background: rgba(254, 75, 9, 0.08);\n  color: var(--ama-orange);\n  font-size: 13px;\n  font-weight: 900;\n  white-space: nowrap;\n}\n\n.ama-bsafe-list {\n  list-style: none;\n  padding: 0;\n  margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n  position: relative;\n  padding: 15px 18px 15px 44px;\n  margin-bottom: 10px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 18px;\n  background: rgba(255, 255, 255, 0.84);\n  box-shadow:\n    0 6px 18px rgba(0, 76, 150, 0.035),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  color: var(--ama-text);\n  font-size: 15px;\n  line-height: 1.62;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n  content: \"\";\n  position: absolute;\n  left: 18px;\n  top: 22px;\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n  margin: 22px 0;\n  padding: 18px 20px;\n  border: 1px solid rgba(0, 76, 150, 0.10);\n  border-radius: 18px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  color: var(--ama-muted);\n  font-size: 14px;\n  line-height: 1.62;\n  font-style: italic;\n  box-shadow:\n    0 8px 20px rgba(0, 76, 150, 0.04),\n    inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n  margin: 28px 0;\n  padding: 24px;\n  border-radius: 22px;\n  background:\n    radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n    linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n  box-shadow:\n    0 16px 34px rgba(254, 75, 9, 0.22),\n    inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n  color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n  margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n  margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n  display: grid;\n  gap: 12px;\n  margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 18px;\n  background: rgba(255, 255, 255, 0.86);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n  cursor: pointer;\n  padding: 18px 50px 18px 18px;\n  color: var(--ama-blue);\n  font-weight: 900;\n  line-height: 1.35;\n  list-style: none;\n  position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n  display: none;\n}\n\n.ama-bsafe-faq summary::after {\n  content: \"+\";\n  position: absolute;\n  right: 18px;\n  top: 50%;\n  transform: translateY(-50%);\n  color: var(--ama-orange);\n  font-size: 24px;\n  line-height: 1;\n  font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n  content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n  padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n  margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n  margin-top: 30px;\n  padding: 24px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 24px;\n  background:\n    radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n    linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  box-shadow:\n    0 14px 34px rgba(0, 76, 150, 0.08),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n  margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  min-height: 46px;\n  padding: 12px 22px;\n  border-radius: 999px;\n  background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n  color: #ffffff !important;\n  font-weight: 900;\n  text-decoration: none;\n  box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n  margin-top: 30px;\n  padding-top: 22px;\n  border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n  margin: 0;\n  color: var(--ama-muted);\n  font-size: 13px;\n  line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n  max-width: 1180px;\n  margin: 32px auto 0;\n  padding: 24px;\n  border: 1px solid rgba(0, 76, 150, 0.18);\n  border-radius: 22px;\n  background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n  box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n  color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n  margin: 0 0 8px;\n  font-size: 13px;\n  letter-spacing: 0.08em;\n  text-transform: uppercase;\n  font-weight: 900;\n  color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n  margin: 0 0 12px;\n  color: #004c96;\n  font-size: clamp(22px, 2.4vw, 30px);\n  line-height: 1.15;\n  font-weight: 900;\n  letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n  margin: 0 0 10px;\n  line-height: 1.65;\n  color: #184b78;\n  font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n  margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n  .ama-bsafe-grid {\n    grid-template-columns: repeat(2, minmax(0, 1fr));\n  }\n\n  .ama-bsafe-substance-row {\n    display: grid;\n    grid-template-columns: 130px minmax(0, 1fr);\n    align-items: start;\n    gap: 10px 14px;\n  }\n\n  .ama-bsafe-substance-code {\n    grid-column: 1;\n    grid-row: 1;\n  }\n\n  .ama-bsafe-substance-threshold {\n    grid-column: 2;\n    grid-row: 1;\n    justify-self: start;\n    margin-left: 0;\n  }\n\n  .ama-bsafe-substance-main {\n    grid-column: 1 \/ -1;\n    grid-row: 2;\n    min-width: 0;\n    width: 100%;\n  }\n}\n\n@media (max-width: 640px) {\n  .ama-bsafe-panel {\n    border-radius: 22px;\n  }\n\n  .ama-bsafe-inner {\n    padding: 24px 14px;\n  }\n\n  .ama-bsafe-title {\n    font-size: clamp(28px, 8.4vw, 36px);\n    letter-spacing: -0.035em;\n  }\n\n  .ama-bsafe-summary-strip {\n    display: grid;\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-summary-item {\n    border-radius: 16px;\n  }\n\n  .ama-bsafe-accordion {\n    gap: 10px;\n  }\n\n  .ama-bsafe-item {\n    border-radius: 20px;\n  }\n\n  .ama-bsafe-item summary {\n    min-height: 60px;\n    padding: 12px 52px 12px 15px;\n  }\n\n  .ama-bsafe-item summary::after {\n    right: 14px;\n    width: 32px;\n    height: 32px;\n    font-size: 20px;\n  }\n\n  .ama-bsafe-item[open] summary::after {\n    font-size: 22px;\n  }\n\n  .ama-bsafe-acc-title {\n    font-size: 15px;\n    line-height: 1.18;\n    letter-spacing: -0.014em;\n  }\n\n  .ama-bsafe-acc-sub {\n    font-size: 12.2px;\n    line-height: 1.22;\n  }\n\n  .ama-bsafe-content {\n    padding: 20px 15px;\n  }\n\n  .ama-bsafe-content h2 {\n    font-size: clamp(24px, 7vw, 30px);\n  }\n\n  .ama-bsafe-grid {\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-card {\n    padding: 20px;\n  }\n\n  .ama-bsafe-substance-row {\n    padding: 16px;\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-substance-code {\n    width: fit-content;\n    min-width: 0;\n    max-width: 100%;\n  }\n\n  .ama-bsafe-substance-threshold {\n    grid-column: 1;\n    grid-row: auto;\n  }\n\n  .ama-bsafe-validation {\n    padding: 20px;\n    border-radius: 20px;\n  }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Test Urinaire 13 Drogues Drugdiag® 13T\"\u003e\n  \u003cdiv class=\"ama-bsafe-panel\"\u003e\n    \u003cdiv class=\"ama-bsafe-inner\"\u003e\n      \u003cheader class=\"ama-bsafe-header\"\u003e\n        \u003cspan class=\"ama-bsafe-kicker\"\u003eTest urinario professionale\u003c\/span\u003e\n        \u003ch2 class=\"ama-bsafe-title\"\u003eTest Urinario 13 Droghe Drugdiag® 13T\u003c\/h2\u003e\n        \u003cdiv class=\"ama-bsafe-lead\"\u003e\n          \u003cp style=\"font-size: 17px; line-height: 1.8; margin-bottom: 15px;\"\u003e\n        Il \u003cstrong\u003etest urinario Drugdiag® T13\u003c\/strong\u003e è un dispositivo di screening multi-droga che consente di ricercare simultaneamente \u003cstrong\u003e13 famiglie di sostanze\u003c\/strong\u003e nelle urine. È progettato per professionisti della salute, imprese, strutture di prevenzione e privati che desiderano effettuare un controllo rapido, affidabile e facile da interpretare.\n      \u003c\/p\u003e\n\n      \u003cp style=\"font-size: 16px; line-height: 1.7; margin: 0;\"\u003e\n        Questo test non rileva droghe sintetiche come 3-MMC, 4-MMC, 2-MMC, PTC \/ Buddha Blue, MDPV o α-PVP. Il Drugdiag® T13 mira precisamente alle seguenti famiglie: \u003cstrong\u003eTHC, AMP, BAR, BZO, BUP, COC, MDMA, MET, MTD, MOP, TCA, TML e FYL\u003c\/strong\u003e.\n      \u003c\/p\u003e\n\n      \u003ch3 style=\"color: #004C96;\"\u003e🧪 Sostanze rilevate dal Drugdiag® T13:\u003c\/h3\u003e\n      \u003cul\u003e\n        \u003cli\u003e\n\u003cstrong\u003eTHC:\u003c\/strong\u003e cannabis \/ THC-COOH.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eAMP:\u003c\/strong\u003e anfetamine.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eBAR:\u003c\/strong\u003e barbiturici.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eBZO:\u003c\/strong\u003e benzodiazepine.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eBUP:\u003c\/strong\u003e buprenorfina.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eCOC:\u003c\/strong\u003e cocaina.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eMDMA:\u003c\/strong\u003e ecstasy.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eMET:\u003c\/strong\u003e metamfetamine.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eMTD:\u003c\/strong\u003e metadone.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eMOP:\u003c\/strong\u003e oppiacei \/ morfina.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eTCA:\u003c\/strong\u003e antidepressivi triciclici.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eTML:\u003c\/strong\u003e tramadolo.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eFYL:\u003c\/strong\u003e fentanyl.\u003c\/li\u003e\n      \u003c\/ul\u003e\n        \u003c\/div\u003e\n      \u003c\/header\u003e\n      \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n        \u003cdetails class=\"ama-bsafe-item\" open\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003ePerché scegliere il test urinario Drugdiag® T13?\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003ePerché scegliere il test urinario Drugdiag® T13? Ampio screening in un’unica analisi…\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003ePerché scegliere il test urinario Drugdiag® T13?\u003c\/h2\u003e\n\u003cdiv class=\"ama-bsafe-grid\"\u003e\n      \u003cdiv class=\"ama-bsafe-card\"\u003e\n        \u003ch3 style=\"margin-top: 0;\"\u003eAmpio screening in un’unica analisi\u003c\/h3\u003e\n        \u003cp style=\"margin-bottom: 0;\"\u003e\n          Il Drugdiag® T13 consente di controllare 13 famiglie di sostanze con un solo dispositivo. È particolarmente utile quando è necessario uno screening urinario completo, soprattutto in contesti professionali, medici, preventivi o personali.\n        \u003c\/p\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv class=\"ama-bsafe-card\"\u003e\n        \u003ch3 style=\"margin-top: 0;\"\u003eLettura rapida e semplice\u003c\/h3\u003e\n        \u003cp style=\"margin-bottom: 10px;\"\u003e\n          Il test è progettato per un uso pratico: prelievo urinario, contatto con il campione, quindi lettura visiva del risultato in pochi minuti secondo le indicazioni del foglio illustrativo.\n        \u003c\/p\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv class=\"ama-bsafe-card\"\u003e\n        \u003ch3 style=\"margin-top: 0;\"\u003eSoluzione professionale\u003c\/h3\u003e\n        \u003cp style=\"margin-bottom: 0;\"\u003e\n          Adatto a imprese, professionisti della salute, strutture di prevenzione e privati, questo test offre una soluzione affidabile per identificare rapidamente la presenza eventuale di sostanze comunemente ricercate.\n        \u003c\/p\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eI punti di forza del Drugdiag® T13\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eI punti di forza del Drugdiag® T13 13 famiglie ricercate: THC, AMP, BAR, BZO, BUP,…\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eI punti di forza del Drugdiag® T13\u003c\/h2\u003e\n\u003cul\u003e\n      \u003cli\u003e\n\u003cstrong\u003e13 famiglie ricercate:\u003c\/strong\u003e THC, AMP, BAR, BZO, BUP, COC, MDMA, MET, MTD, MOP, TCA, TML e FYL.\u003c\/li\u003e\n      \u003cli\u003e\n\u003cstrong\u003eFormato urinario:\u003c\/strong\u003e adatto alla rilevazione di numerosi metaboliti eliminati nelle urine.\u003c\/li\u003e\n      \u003cli\u003e\n\u003cstrong\u003eRisultato rapido:\u003c\/strong\u003e lettura visiva in pochi minuti secondo il protocollo d’uso.\u003c\/li\u003e\n      \u003cli\u003e\n\u003cstrong\u003eUso versatile:\u003c\/strong\u003e aziende, salute, prevenzione, enti locali, strutture specializzate e auto-controllo.\u003c\/li\u003e\n      \u003cli\u003e\n\u003cstrong\u003eProduzione francese:\u003c\/strong\u003e dispositivo della gamma Drugdiag® del laboratorio Toda Pharma.\u003c\/li\u003e\n      \u003cli\u003e\n\u003cstrong\u003eQualità professionale:\u003c\/strong\u003e dispositivo medico per diagnostica in vitro con marcatura CE.\u003c\/li\u003e\n    \u003c\/ul\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eTabella delle 13 famiglie rilevate\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eTabella delle 13 famiglie rilevate Il Drugdiag® T13 non deve essere confuso con un…\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eTabella delle 13 famiglie rilevate\u003c\/h2\u003e\n\u003cp\u003e\n      Il Drugdiag® T13 non deve essere confuso con un test specifico per le nuove droghe di sintesi. Ricerca le seguenti famiglie di sostanze:\n    \u003c\/p\u003e\n\n    \u003ctable style=\"width: 100%;\" class=\"ama-bsafe-table\"\u003e\n      \u003cthead\u003e\n        \u003ctr\u003e\n          \u003cth style=\"width: 25%;\"\u003eCodice\u003c\/th\u003e\n          \u003cth style=\"width: 35%;\"\u003eFamiglia rilevata\u003c\/th\u003e\n          \u003cth style=\"width: 40%;\"\u003eEsempi \/ uso dello screening\u003c\/th\u003e\n        \u003c\/tr\u003e\n      \u003c\/thead\u003e\n      \u003ctbody\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eTHC\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eCannabis\u003c\/td\u003e\n          \u003ctd\u003eRicerca del THC-COOH, principale metabolita della cannabis nelle urine.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eAMP\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eAnfetamine\u003c\/td\u003e\n          \u003ctd\u003eScreening delle anfetamine e sostanze affini secondo le soglie del test.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eBAR\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eBarbiturici\u003c\/td\u003e\n          \u003ctd\u003eRicerca di barbiturici, sostanze sedative oggi meno comuni ma ancora monitorate.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eBZO\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eBenzodiazepine\u003c\/td\u003e\n          \u003ctd\u003eFamiglia di farmaci ansiolitici, ipnotici o sedativi che possono alterare la vigilanza.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eBUP\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eBuprenorfina\u003c\/td\u003e\n          \u003ctd\u003eRicerca della buprenorfina, in particolare nel contesto di monitoraggio o controllo di sostanze oppioidi.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eCOC\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eCocaina\u003c\/td\u003e\n          \u003ctd\u003eScreening della cocaina e dei suoi metaboliti urinari.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eMDMA\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eEcstasy\u003c\/td\u003e\n          \u003ctd\u003eRicerca di MDMA, sostanza stimolante frequentemente associata all’ambiente festivo.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eMET\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eMetamfetamine\u003c\/td\u003e\n          \u003ctd\u003eScreening delle metamfetamine secondo le soglie previste dal dispositivo.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eMTD\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eMetadone\u003c\/td\u003e\n          \u003ctd\u003eRicerca della metadone, in particolare nei contesti di monitoraggio o controllo degli oppioidi.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eMOP\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eOppiacei \/ morfina\u003c\/td\u003e\n          \u003ctd\u003eScreening degli oppiacei naturali e affini, secondo le prestazioni del test.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eTCA\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eAntidepressivi triciclici\u003c\/td\u003e\n          \u003ctd\u003eRicerca degli TCA, famiglia di farmaci che può essere monitorata in alcuni contesti clinici.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eTML\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eTramadolo\u003c\/td\u003e\n          \u003ctd\u003eScreening del tramadolo, analgesico oppioide che può alterare la vigilanza e presentare rischi di uso improprio.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eFYL\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eFentanyl\u003c\/td\u003e\n          \u003ctd\u003eRicerca del fentanyl, oppioide potente che richiede particolare attenzione nei contesti di prevenzione e salute.\u003c\/td\u003e\n        \u003c\/tr\u003e\n      \u003c\/tbody\u003e\n    \u003c\/table\u003e\n\n    \u003cp class=\"ama-bsafe-note\"\u003e\n      Le famiglie rilevate devono sempre essere verificate con il foglio illustrativo del prodotto e le soglie indicate dal produttore. Un test rapido fornisce un risultato orientativo; in caso di dubbio, un risultato deve essere confermato da un’analisi di laboratorio.\n    \u003c\/p\u003e\n\n    \u003cdiv class=\"ama-bsafe-alert\"\u003e\n      \u003ch3\u003e⚠️ Importante: questo test non rileva droghe di sintesi specifiche\u003c\/h3\u003e\n      \u003cp\u003e\n        Il Drugdiag® T13 non deve essere presentato come un test di screening per le catinoni di sintesi o i cannabinoidi di sintesi.\n      \u003c\/p\u003e\n      \u003cp\u003e\n        Non è specificamente mirato a sostanze come la \u003cstrong\u003e3-MMC\u003c\/strong\u003e, la \u003cstrong\u003e4-MMC\u003c\/strong\u003e, la \u003cstrong\u003e2-MMC\u003c\/strong\u003e, il \u003cstrong\u003ePTC \/ Buddha Blue\u003c\/strong\u003e, il \u003cstrong\u003eMDPV\u003c\/strong\u003e o l’\u003cstrong\u003eα-PVP\u003c\/strong\u003e.\n      \u003c\/p\u003e\n      \u003cp\u003e\n        Per ricercare queste sostanze, è necessario utilizzare un test adatto alle nuove sostanze psicoattive e alle droghe di sintesi.\n      \u003c\/p\u003e\n    \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eIn quali casi utilizzare il Drugdiag® T13?\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eIn quali casi utilizzare il Drugdiag® T13? Aziende e prevenzione Il test può essere…\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eIn quali casi utilizzare il Drugdiag® T13?\u003c\/h2\u003e\n\u003cdiv class=\"ama-bsafe-grid\"\u003e\n      \u003cdiv class=\"ama-bsafe-card\"\u003e\n        \u003ch3 style=\"margin-top: 0;\"\u003eAziende e prevenzione\u003c\/h3\u003e\n        \u003cp style=\"margin-bottom: 0;\"\u003e\n          Il test può essere integrato in un approccio di prevenzione dei rischi in azienda, in particolare per i ruoli di sicurezza o gli ambienti sensibili, nel rispetto del quadro legale applicabile, del regolamento interno e della riservatezza dei risultati.\n        \u003c\/p\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv class=\"ama-bsafe-card\"\u003e\n        \u003ch3 style=\"margin-top: 0;\"\u003eOperatori sanitari\u003c\/h3\u003e\n        \u003cp style=\"margin-bottom: 0;\"\u003e\n          Costituisce uno strumento di screening rapido per indirizzare un intervento, un monitoraggio o una richiesta di conferma biologica quando il contesto clinico lo richiede.\n        \u003c\/p\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv class=\"ama-bsafe-card\"\u003e\n        \u003ch3 style=\"margin-top: 0;\"\u003ePrivati e auto-controllo\u003c\/h3\u003e\n        \u003cp style=\"margin-bottom: 0;\"\u003e\n          Il Drugdiag® T13 può essere utilizzato da privati che desiderano effettuare un auto-controllo urinario ampio, con una lettura semplice e rapida del risultato.\n        \u003c\/p\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eScreening, prevenzione e sottomissione chimica\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eScreening, prevenzione e sottomissione chimica Il Drugdiag® T13 può contribuire a un…\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eScreening, prevenzione e sottomissione chimica\u003c\/h2\u003e\n\u003cp\u003e\n      Il Drugdiag® T13 può contribuire a un approccio di prevenzione ampio, in particolare quando è necessario ricercare diverse famiglie di sostanze come le benzodiazepine, gli oppiacei, il tramadolo, il fentanyl, la metadone, la cocaina, le anfetamine o la cannabis.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      Tuttavia, non consente di ricercare tutte le sostanze che potrebbero essere coinvolte in una situazione di sottomissione chimica. Non sostituisce un intervento medico, una denuncia né un’analisi tossicologica specializzata effettuata da un laboratorio.\n    \u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eContenuto della bustina\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eContenuto della bustina Il prodotto è confezionato per garantire un utilizzo semplice e…\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eContenuto della bustina\u003c\/h2\u003e\n\u003cp\u003e\n      Il prodotto è confezionato per garantire un utilizzo semplice e igienico:\n    \u003c\/p\u003e\n\n    \u003cul\u003e\n      \u003cli\u003e1 test urinario Drugdiag® T13.\u003c\/li\u003e\n      \u003cli\u003e1 foglietto illustrativo secondo il confezionamento del produttore.\u003c\/li\u003e\n      \u003cli\u003eRisultato leggibile direttamente sul dispositivo dopo l’esecuzione del test.\u003c\/li\u003e\n    \u003c\/ul\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eCompetenza clinica \u0026amp; qualità del dispositivo\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eCompetenza clinica \u0026amp; qualità del dispositivo Tecnologia di screening rapido Il Drugdiag®…\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eCompetenza clinica \u0026amp; qualità del dispositivo\u003c\/h2\u003e\n\u003ch3\u003eTecnologia di screening rapido\u003c\/h3\u003e\n    \u003cp\u003e\n      Il Drugdiag® T13 si basa su una tecnologia immunocromatografica che permette di ricercare rapidamente la possibile presenza di diverse famiglie di sostanze in un campione urinario.\n    \u003c\/p\u003e\n\n    \u003ch3\u003eDispositivo medico di diagnostica in vitro\u003c\/h3\u003e\n    \u003cp\u003e\n      Questo test è un dispositivo medico di diagnostica \u003ci\u003ein vitro\u003c\/i\u003e. Porta la marcatura \u003cstrong\u003eCE\u003c\/strong\u003e ai sensi della normativa applicabile ai dispositivi diagnostici.\n    \u003c\/p\u003e\n\n    \u003ch3\u003eProduzione francese e qualità Toda Pharma\u003c\/h3\u003e\n    \u003cp\u003e\n      Il Drugdiag® T13 appartiene alla gamma Drugdiag® del laboratorio francese \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, attore riconosciuto nel test diagnostico rapido. Risponde a un’esigenza di qualità professionale adatta agli usi di screening, prevenzione e salute.\n    \u003c\/p\u003e\n\n    \u003cdiv class=\"certifications\"\u003e\n      \u003cspan class=\"cert-badge\"\u003eCE\u003c\/span\u003e\n      \u003cspan class=\"cert-badge\"\u003eDiagnostica in vitro\u003c\/span\u003e\n      \u003cspan class=\"cert-badge\"\u003eToda Pharma\u003c\/span\u003e\n      \u003cspan class=\"cert-badge\"\u003eProduzione francese\u003c\/span\u003e\n      \u003cspan class=\"cert-badge\"\u003eUso professionale\u003c\/span\u003e\n    \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eConsigli per l’uso\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eConsigli per l’uso Leggere attentamente il foglietto illustrativo prima dell’uso. Utilizzare un…\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eConsigli per l’uso\u003c\/h2\u003e\n\u003cul\u003e\n      \u003cli\u003eLeggere attentamente il foglietto illustrativo prima dell’uso.\u003c\/li\u003e\n      \u003cli\u003eUtilizzare un campione urinario pulito, in condizioni adeguate.\u003c\/li\u003e\n      \u003cli\u003eRispettare il tempo di lettura indicato dal produttore.\u003c\/li\u003e\n      \u003cli\u003eNon interpretare il risultato oltre il tempo raccomandato.\u003c\/li\u003e\n      \u003cli\u003eIn caso di risultato positivo, dubbio o contestato, richiedere una conferma in laboratorio.\u003c\/li\u003e\n    \u003c\/ul\u003e\n\n    \u003cp class=\"ama-bsafe-note\"\u003e\n      Un test urinario rapido è uno strumento di screening e orientamento. Non costituisce da solo una prova medico-legale definitiva. Per qualsiasi decisione medica, professionale o legale, può essere necessaria una conferma tramite analisi tossicologica.\n    \u003c\/p\u003e\n\n    \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e\n      \u003cp\u003e\n        \u003cstrong\u003eAvvertenze legali :\u003c\/strong\u003e Questo dispositivo medico è un prodotto sanitario regolamentato che, ai sensi di tale normativa, porta la marcatura CE. In caso di trattamento medico, risultato positivo, dubbio sull’interpretazione o situazione a rischio, consultare un professionista sanitario o un laboratorio di analisi mediche.\n      \u003c\/p\u003e\n    \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unità","offer_id":56426435117380,"sku":"10413T-A-1","price":33.0,"currency_code":"USD","in_stock":true},{"title":"Confezione da 5","offer_id":56426435150148,"sku":"10413T-A-1","price":164.0,"currency_code":"USD","in_stock":true},{"title":"Confezione da 10","offer_id":56426435182916,"sku":"10413T-A-1","price":310.0,"currency_code":"USD","in_stock":true},{"title":"Confezione da 25","offer_id":56426435215684,"sku":"10413T-A-1","price":693.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/photo_produit_drugdiag_T_de_face_v2.png?v=1779373751","url":"https:\/\/ama-prevention.com\/it\/products\/test-urinario-a-immersione-13-droghe","provider":"AMA Prévention ","version":"1.0","type":"link"}